N-甲基-D-天冬氨酸拮抗剂、精神分裂症与抗精神病药恶性综合征 - Suppr | 超能文献

N-methyl-D-aspartate antagonists, schizophrenia, and neuroleptic malignant syndrome.

作者信息

Weller M, Kornhuber J

出版信息

Arch Neurol. 1992 Sep;49(9):900-1. doi: 10.1001/archneur.1992.00530330018007.

DOI:10.1001/archneur.1992.00530330018007

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

N-methyl-D-aspartate antagonists, schizophrenia, and neuroleptic malignant syndrome.N-甲基-D-天冬氨酸拮抗剂、精神分裂症与抗精神病药恶性综合征

Arch Neurol. 1992 Sep;49(9):900-1. doi: 10.1001/archneur.1992.00530330018007.

2

Glutamate receptor antagonists for neuroleptic malignant syndrome and akinetic hyperthermic parkinsonian crisis.用于治疗抗精神病药恶性综合征和运动不能性高热帕金森危象的谷氨酸受体拮抗剂。

J Neural Transm Park Dis Dement Sect. 1993;6(1):63-72. doi: 10.1007/BF02252624.

3

N-methyl-D-aspartate antagonists in the treatment of Parkinson's disease.N-甲基-D-天冬氨酸拮抗剂在帕金森病治疗中的应用

Arch Neurol. 1991 Sep;48(9):977-81. doi: 10.1001/archneur.1991.00530210109030.

4

D-serine and the therapeutic challenge posed by the N-methyl-D-aspartate antagonist model of schizophrenia.

Biol Psychiatry. 1998 Dec 1;44(11):1075-6. doi: 10.1016/s0006-3223(98)00284-4.

5

A rationale for NMDA receptor antagonist therapy of the neuroleptic malignant syndrome.NMDA受体拮抗剂治疗抗精神病药恶性综合征的理论依据。

Med Hypotheses. 1992 Aug;38(4):329-33. doi: 10.1016/0306-9877(92)90027-a.

6

[Neuroleptic malignant syndrome (dopamine-dependent malignant hyperthermia). 4 different cases].[抗精神病药恶性综合征（多巴胺依赖性恶性高热）。4例不同病例]

Nervenarzt. 1988 Feb;59(2):103-9.

7

N-methyl-D-aspartate (NMDA) antagonist and Parkinson's disease: a pilot study with dextromethorphan.N-甲基-D-天冬氨酸（NMDA）拮抗剂与帕金森病：右美沙芬的一项初步研究

Mov Disord. 1994 Mar;9(2):242-3. doi: 10.1002/mds.870090226.

8

The teratogenicity of N-methyl-D-aspartate (NMDA) receptor antagonists.N-甲基-D-天冬氨酸（NMDA）受体拮抗剂的致畸性。

Pediatr Res. 1998 Sep;44(3):415; author reply 416-7. doi: 10.1203/00006450-199809000-00025.

9

The teratogenicity of N-methyl-D-aspartate (NMDA) receptor antagonists.N-甲基-D-天冬氨酸（NMDA）受体拮抗剂的致畸性。

Pediatr Res. 1998 Sep;44(3):415-7. doi: 10.1203/00006450-199809000-00026.

10

Hyperactivity and disruption of prepulse inhibition induced by N-methyl-D-aspartate stimulation of the ventral hippocampus and the effects of pretreatment with haloperidol and clozapine.N-甲基-D-天冬氨酸刺激腹侧海马诱发的多动及前脉冲抑制障碍，以及氟哌啶醇和氯氮平预处理的影响。

Neuroscience. 2001;103(2):325-35. doi: 10.1016/s0306-4522(00)00589-3.

引用本文的文献

1

Molecular cloning, functional expression, and pharmacological characterization of an N-methyl-D-aspartate receptor subunit from human brain.人脑N-甲基-D-天冬氨酸受体亚基的分子克隆、功能表达及药理学特性

Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5057-61. doi: 10.1073/pnas.90.11.5057.

2

MRI white matter hyperintensity in neuroleptic malignant syndrome (NMS)--a clue to pathogenesis?抗精神病药恶性综合征（NMS）中的MRI白质高信号——发病机制的线索？

J Neural Transm Gen Sect. 1992;90(2):151-9. doi: 10.1007/BF01250797.